EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolism‐Based Biomarkers for Rapid Phenotypic Antibiotic Susceptibility Testing

Sha Yu, Bayinqiaoge, Xi Lu, Xin Wang, Rongfeng Wang, Yi Li iD, Shi-Yang Tang, Chengchen Zhang

Advanced Science · 2026

DOI: 10.1002/advs.75553 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, 2026. Verfasst von Sha Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Digital Health and Biomedical Engineering, School of Electronics and Computer Science, University of Southampton, Southampton, UK. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Biomarkers, Bacteria, Drug Resistance, Bacterial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation (UKRI), UK, Wessex Medical Trust, UK, The Royal Society, UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The accelerating global crisis of antimicrobial resistance (AMR) demands rapid and accurate methods for antibiotic susceptibility testing (AST). Conventional phenotypic assays remain the gold standard but are hindered by long culture times, while genotypic tests cannot reliably predict phenotypic resistance. In recent years, metabolism‐based AST has emerged as a promising alternative, enabling the rapid detection of bacterial responses to antibiotics through shifts in metabolic activity. These approaches bridge molecular speed with phenotypic precision, allowing susceptibility determination within hours, or even minutes, without requiring cell proliferation. In this review, we summarize the latest advances in metabolism‐based biomarkers for rapid AST. First, we discuss how antibiotics influence bacterial metabolism, linking resistance mechanisms to metabolic activities. We then summarize emerging metabolic biomarkers, categorized by their physiological underpinnings: nutrient uptake, respiratory activity, metabolic reprogramming, and enzymatic function. Finally, we list key challenges and future directions toward deployable metabolism‐based AST platforms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBiomarkersBacteriaDrug Resistance, BacterialHumansMicrobial Sensitivity TestsPhenotype

Stichwörter der Autor:innen

antibiotic susceptibility testingbacteriabiomarkermetabolism

Substanzen

Anti-Bacterial AgentsBiomarkers

Autor:innen und Institutionen

  • Digital Health and Biomedical Engineering, School of Electronics and Computer Science, University of Southampton, Southampton, UK.
  • School of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney, New South Wales, Australia.
  • Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.

ORCID-Profile: Yi Li

Förderung

  • UK Research and Innovation (UKRI), UK
  • Wessex Medical Trust, UK
  • The Royal Society, UK

Zitieren

APA

Yu, S., Bayinqiaoge, Lu, X., Wang, X., Wang, R., Li, Y., Tang, S. Y., & Zhang, C. (2026). Metabolism‐Based Biomarkers for Rapid Phenotypic Antibiotic Susceptibility Testing. Advanced Science. https://doi.org/10.1002/advs.75553

Vancouver

Yu S, Bayinqiaoge, Lu X, Wang X, Wang R, Li Y, et al. Metabolism‐Based Biomarkers for Rapid Phenotypic Antibiotic Susceptibility Testing. Advanced Science. 2026. doi:10.1002/advs.75553

BibTeX
@article{Yu2026,
  author = {Yu, Sha and Bayinqiaoge and Lu, Xi and Wang, Xin and Wang, Rongfeng and Li, Yi and Tang, Shi-Yang and Zhang, Chengchen},
  title = {Metabolism‐Based Biomarkers for Rapid Phenotypic Antibiotic Susceptibility Testing},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.75553}
}
Kostenlos starten →